2型糖尿病对无创肝纤维化检测准确性的影响及其临床意义
该研究纳入1051例经肝活检的非酒精性脂肪性肝病患者,比较6种无创检测在有无2型糖尿病人群中的准确性。结果显示2型糖尿病患者无创检测的曲线下面积显著降低,主要因特异度下降,部分与年龄及α2-巨球蛋白水平升高有关;FIB4-振动控制瞬时弹性成像序贯算法准确率在无糖尿病患者为90.3%,在有糖尿病者为79.0%(P<.001)。作者建议在2型糖尿病中一线使用专科检测以诊断进展性肝纤维化。
要点
- 2型糖尿病患者无创肝纤维化检测的曲线下面积显著降低,主要因特异度下降。
- FIB4-振动控制瞬时弹性成像序贯算法准确率无糖尿病者90.3% vs 有糖尿病者79.0%(P<.001)。
- 作者建议在2型糖尿病中一线使用专科检测诊断进展性肝纤维化。
核心结论
- 2型糖尿病中无创检测准确性下降部分源于组间特征差异,也与2型糖尿病本身通过改变某些无创检测生物标志物水平有关。
- 作者建议在2型糖尿病中一线使用专科检测以诊断进展性肝纤维化。
研究设计与样本
- 纳入1051例经肝活检的非酒精性脂肪性肝病患者,比较有无2型糖尿病者6种无创检测的准确性。
- 检测包括血液纤维化检测(Nonalcoholic Fatty Liver Disease Fibrosis Score、FIB4、Fibrotest、FibroMeter)、振动控制瞬时弹性成像及组合弹性-血液检测FibroMeterVCTE。
- 研究终点为肝活检证实的进展性肝纤维化。
主要发现
- 2型糖尿病患者无创检测的受试者工作特征曲线下面积显著降低,主要因特异度下降。
- FIB4特异度下降仅与2型糖尿病患者的较高年龄有关。
- Fibrotest、FibroMeter和FibroMeterVCTE特异度下降与年龄及较高的α2-巨球蛋白水平有关。
- 敏感度不受2型糖尿病影响,但因该人群中进展性肝纤维化患病率翻倍,假阴性绝对数翻倍。
- FIB4-振动控制瞬时弹性成像序贯算法准确率无糖尿病者90.3% vs 有糖尿病者79.0%(P<.001)。
关键数值与推荐
- FIB4-振动控制瞬时弹性成像序贯算法准确率:无2型糖尿病者90.3%,有2型糖尿病者79.0%(P<.001)。
- 2型糖尿病中进展性肝纤维化患病率为无糖尿病者的2倍。
临床怎么用
- 作者建议在2型糖尿病中一线使用专科检测以诊断进展性肝纤维化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Noninvasive tests (NITs) of liver fibrosis have been suggested to be less accurate in type 2 diabetes mellitus (T2DM). We aimed to compare the accuracy of 6 NITs between patients with or without T2DM, explain any differences, and adapt diagnostic algorithms for clinical practice accordingly. METHODS: We included 1051 patients with nonalcoholic fatty liver disease with liver biopsy, blood fibrosis tests (Nonalcoholic Fatty Liver Disease Fibrosis Score, FIB4, Fibrotest, FibroMeter), vibration-controlled transient elastography (VCTE), and the combinatory elasto-blood test FibroMeterVCTE. The study endpoint was advanced fibrosis on liver biopsy. RESULTS: NIT areas under the receiver operating characteristic curve were significantly lower in patients with T2DM, mostly because of a decrease in specificity. For FIB4, this decrease in specificity was only related to the higher age of patients with T2DM enrolled. For Fibrotest, FibroMeter, and FibroMeterVCTE, the decrease in specificity was related to age but also to higher alpha2-macroglobulin level, which is known to increase in T2DM. Sensitivity was unaffected by T2DM, but it masked a doubled raw number of false negatives because of the 2-fold higher prevalence of advanced fibrosis in that setting. The sequential algorithm FIB4-vibration-controlled transient elastography had 90.3% accuracy in patients without T2DM vs 79.0% in those with (P < .001). Algorithms using first-line specialized tests maintained a low rate of false negatives and false positives in T2DM. CONCLUSIONS: The decrease in NIT accuracy observed in T2DM is partly biased by the different characteristics of the groups studied, but also linked to T2DM itself through modification of the levels of some NIT biomarkers. Specialized tests should be used first-line to diagnose advanced liver fibrosis in T2DM.
引用
- Boursier J, Canivet CM, Costentin C, et al. Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications. Clin Gastroenterol Hepatol. 2022. PMID: 35288342. doi:10.1016/j.cgh.2022.02.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。